Iovance Biotherapeutics, Inc. IOVA Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Iovance Biotherapeutics, Inc.’s reported figures.
Based on the most recent quarter.
The official record: Iovance Biotherapeutics, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Iovance Biotherapeutics, Inc.'s current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Iovance Biotherapeutics, Inc.'s current ratio?
- Iovance Biotherapeutics, Inc. (IOVA) reported current ratio of 3.6× in Q1 2026.
- How has Iovance Biotherapeutics, Inc.'s current ratio changed year-over-year?
- Iovance Biotherapeutics, Inc.'s current ratio decreased by 13.7% year-over-year, from 4.2× to 3.6×.
- What is the long-term trend for Iovance Biotherapeutics, Inc.'s current ratio?
- Over 5 years (2020 to 2025), Iovance Biotherapeutics, Inc.'s current ratio has grown at a -22.7% compound annual growth rate (CAGR), from 11.6× to 3.2×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.